Zarxio Injection, Solution
Product Images NDC 61314-326

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Zarxio (NDC 61314-326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Safety Device (Zarxio 01)

An instructional diagram of a syringe illustrating components such as needle cap, needle guard, finger grips, viewing window showing label and expiration date, dose markings, conical base of plunger stopper, plunger stopper with guard wings, plunger, and plunger head.*

FDA Label Image

Fig B (Zarxio 02)

An instructional illustration showing four items in sequence: a wipe packet labeled "WIPE," a cloth or pad, a sharps disposal container labeled "SHARPS" with a biohazard symbol, and an adhesive bandage. The items appear to represent steps or components for injection site care and disposal.*

FDA Label Image

Activated Do Not Use (Zarxio 03)

An illustration showing the internal components and mechanism of a prefilled syringe for injection. The diagram details the syringe barrel, plunger, needle base, and internal spring mechanism, likely representing the injection system for administering the filgrastim-sndz solution in ZARXIO.*

FDA Label Image

Ready To Use (Zarxio 04)

An illustration of an injection device featuring a barrel with measurement markings, a plunger, and a needle cap. The device is designed for subcutaneous or intravenous delivery of medication, consistent with injection solutions like filgrastim-sndz.*

FDA Label Image

Front Injection Areas (Zarxio 05)

An instructional illustration showing recommended injection sites on a male body for ZARXIO (filgrastim-sndz) injection. Highlighted areas include the upper arms, abdomen, and upper thighs, indicating where subcutaneous or intravenous injections can be administered.*

FDA Label Image

Back Injection Areas (Zarxio 06)

Illustration showing the recommended injection sites for ZARXIO (filgrastim-sndz) injection. The sites highlighted include the upper arm, abdomen, and upper thigh, indicating possible areas for subcutaneous or intravenous injection.*

FDA Label Image

How To Remove Needle Cap (Zarxio 07)

An instructional illustration showing one hand holding a syringe and the other hand removing a protective cap from the syringe needle, indicated by an upward arrow. This diagram likely demonstrates a step in preparing the ZARXIO injection, filgrastim-sndz, for intravenous or subcutaneous administration.*

FDA Label Image

Check Syringe For Air Bubble (Zarxio 08)

Illustration showing how to prepare a syringe for injection of ZARXIO (filgrastim-sndz), including steps to remove the needle cap by pulling it straight off before administering the injection.*

FDA Label Image

Positions (Zarxio 09)

An instructional illustration showing how to set the dose on a syringe injector for ZARXIO (filgrastim-sndz) injection. It depicts two hands adjusting the plunger with arrows and close-up views of the dose number settings (0.3, 0.4, 0.5 mL) marked on the syringe barrel, explaining the initial position and partial dose setting steps.*

FDA Label Image

How To Place Injection (Zarxio 10)

An instructional line drawing showing a hand holding a syringe to administer an injection into the finger of the other hand. This likely illustrates the subcutaneous or intravenous injection technique for ZARXIO (filgrastim-sndz) injection solution.*

FDA Label Image

How To Fully Inject (Zarxio 11)

An instructional line drawing showing a hand holding a syringe for injection and the fingers preparing the injection site by stretching the skin. A magnified inset highlights details of the syringe and fingers positioning for subcutaneous or intravenous injection.*

FDA Label Image

How To Remove Injection (Zarxio 12)

An instructional line drawing illustrating the proper hand positioning for administering an injection with a syringe, showing a hand holding the syringe and preparing to inject into the skin.*

FDA Label Image

How To Lock Safety Device (Zarxio 13)

Illustration showing a hand holding a syringe-type device and preparing or modifying a component, likely related to the administration of ZARXIO filgrastim-sndz injection solution. The image depicts detailed fingers manipulating the syringe parts, suggesting an instructional usage step.*

FDA Label Image

How To Dispose Of Safety Device (Zarxio 14)

An instructional illustration showing a hand disposing of a syringe into a container labeled 'SHARPS' with a biohazard symbol, depicting proper disposal of injection sharps. This is relevant for ZARXIO filgrastim-sndz injection solution usage.*

FDA Label Image

300mcg Labal (Zarxio 15)

Zarxio (filgrastim-sndz) Injection, 300 mcg per 0.5 mL single-dose prefilled syringe, labeled for subcutaneous or intravenous use. The label notes absence of preservatives, refrigeration requirement, and caution about natural rubber latex. Manufactured by Sandoz Inc., a Novartis company.*

FDA Label Image

480mcg Label (Zarxio 16)

Zarxio (filgrastim-sndz) injection, solution in 480 mcg/0.8 mL strength for subcutaneous or intravenous use. The label indicates a single-dose prefilled syringe with needle guard. Manufactured by Sandoz Inc., the product is a recombinant Granulocyte Colony-Stimulating Factor derived from E. coli and contains no preservative.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.